Schizophrenia has long been framed as a disorder of broken thoughts and fractured perception, but a new line of research ...

As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...

A major scientific review reveals a deep knowledge gap in how cognition is affected when schizophrenia and personality disorders occur together.

A new study by a research team at Université de Montréal highlights a critical lack of knowledge about the cognitive profiles ...

Adjunctive treatment with the GLP-1 agonist semaglutide significantly reduces the antipsychotic-related cardiometabolic risk ...

Schizotypal personality disorder and schizoaffective disorder are distinct conditions that cause different symptoms. Learn how doctors tell them apart here.

Advocating for rights for people with schizophrenia is a tough lifestyle. In fact, there are only a handful of activists in the United States who have successfully executed writing a memoir, starting ...

Schizophrenia spectrum disorders significantly increase cardiovascular and metabolic disease risks, partly due to antipsychotic-induced weight gain and glucose dysregulation.

Researchers from the Psychiatric Genomics Consortium (PGC) report that most genetic influences on mental illness are shared across diagnostic categories, revealing a more interconnected biological ...

Schizoaffective disorder is a combination of schizophrenia and a major mood disorder – such as depression or bipolar disorder. Individuals with schizoaffective disorder experience a combination of ...

Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...